These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1726015)

  • 1. The CD4 receptor: post binding events, conformational change and the second site.
    Wilks D
    Mol Aspects Med; 1991; 12(4):255-65. PubMed ID: 1726015
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro binding and internalization of HIV envelope glycoproteins by human epidermal Langerhans cells does not require the CD4-gp120-binding site.
    Schmitt D; Dezutter-Dambuyant C; Hanau D; Kolbe HV; Kieny MP; Cazenave JP; Thivolet J
    Res Virol; 1990; 141(2):209-15. PubMed ID: 1693220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic analysis of the HIV envelope binding domain on CD4.
    Arthos J; Deen KC; Shatzman A; Truneh A; Rosenberg M; Sweet RW
    Ann N Y Acad Sci; 1990; 616():116-24. PubMed ID: 2078013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 encoded virus protein U (Vpu) solution structure of the 41-62 hydrophilic region containing the phosphorylated sites Ser52 and Ser56.
    Coadou G; Evrard-Todeschi N; Gharbi-Benarous J; Benarous R; Girault JP
    Int J Biol Macromol; 2002 Mar; 30(1):23-40. PubMed ID: 11893391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of receptor binding and viral tropism.
    Cordonnier A; Montagnier L
    Adv Exp Med Biol; 1991; 300():17-26. PubMed ID: 1781343
    [No Abstract]   [Full Text] [Related]  

  • 6. Dependence of conformation of D3/D4 domains of human CD4 on glycosylation and membrane attachment.
    Lideman LF; Gibadulin RA
    Biochemistry (Mosc); 2009 Feb; 74(2):194-200. PubMed ID: 19267675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
    Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
    J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV gets a taste of its own medicine.
    Cohen J
    Science; 1997 Sep; 277(5332):1606. PubMed ID: 9312856
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of CD4 in the penetration of cells by HIV.
    McDougal JS; Maddon PJ; Orloff G; Clapham PR; Dalgleish AG; Jamal S; Weiss RA; Axel RA
    Adv Exp Med Biol; 1991; 300():145-54; discussion 155-8. PubMed ID: 1685856
    [No Abstract]   [Full Text] [Related]  

  • 10. Skepticism greets HIV coreceptor.
    Balter M
    Science; 1993 Nov; 262(5135):843-4. PubMed ID: 7901911
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.
    Liu L; Patel B; Ghanem MH; Bundoc V; Zheng Z; Morgan RA; Rosenberg SA; Dey B; Berger EA
    J Virol; 2015 Jul; 89(13):6685-94. PubMed ID: 25878112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigators detail HIV's fatal handshake.
    Cohen J
    Science; 1996 Oct; 274(5287):502. PubMed ID: 8928003
    [No Abstract]   [Full Text] [Related]  

  • 13. CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5.
    Raja A; Venturi M; Kwong P; Sodroski J
    J Virol; 2003 Jan; 77(1):713-8. PubMed ID: 12477875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site.
    Fleury S; Lamarre D; Meloche S; Ryu SE; Cantin C; Hendrickson WA; Sekaly RP
    Cell; 1991 Sep; 66(5):1037-49. PubMed ID: 1889086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes.
    Sattentau QJ; Arthos J; Deen K; Hanna N; Healey D; Beverley PC; Sweet R; Truneh A
    J Exp Med; 1989 Oct; 170(4):1319-34. PubMed ID: 2477490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV: conformational camouflage.
    Jardetzky T
    Nature; 2002 Dec; 420(6916):623-4. PubMed ID: 12478278
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites.
    Kwong PD; Doyle ML; Casper DJ; Cicala C; Leavitt SA; Majeed S; Steenbeke TD; Venturi M; Chaiken I; Fung M; Katinger H; Parren PW; Robinson J; Van Ryk D; Wang L; Burton DR; Freire E; Wyatt R; Sodroski J; Hendrickson WA; Arthos J
    Nature; 2002 Dec; 420(6916):678-82. PubMed ID: 12478295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypsin-resistant gp120 receptors are upregulated on short-term cultured human epidermal Langerhans cells.
    Dezutter-Dambuyant C; Schmitt DA; Dusserre N; Hanau D; Kolbe HV; Kieny MP; Gazzolo L; Macé K; Pasquali JL; Olivier R
    Res Virol; 1991; 142(2-3):129-38. PubMed ID: 1896637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine immunoglobulin G anti-CD4 monoclonal antibodies bind to primary human monocytes and macrophages through Fc receptors as well as authentic CD4.
    Teppler H; Lee SH; Rieber EP; Gordon S
    AIDS; 1990 Jul; 4(7):627-32. PubMed ID: 2397055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystein 402 of HIV gp 120 is essential for CD4-binding and resistance of gp 120 to intracellular degradation.
    Hemming A; Bolmstedt A; Flodby P; Lundberg L; Gidlund M; Wigzell H; Olofsson S
    Arch Virol; 1989; 109(3-4):269-76. PubMed ID: 2558637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.